Stockreport

Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]

Dermata Therapeutics, Inc.  (DRMA) 
PDF - Raised $9.1 million in gross proceeds from three financings completed in 2023 - - Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis [Read more]